HMGN5 and hepatocellular carcinoma: Zuo et al. equipped DEX with a hepatocellular carcinoma (HCC)-targeting peptide-P47, an immunoadjuvant high mobility group nucleosome-binding protein 1 (HMGN1) and an α-fetoprotein epitope (Zuo et al., 2022).